Use of Sodium Glucose Cotransporter 2 Inhibitors in the Hands of Cardiologists: With Great Power Comes Great Responsibility.

Circulation

From Division of Nephrology, Department of Medicine (D.Z.I.C.) and Peter Munk Cardiac Centre (J.A.U.), Toronto General Hospital, Toronto, ON, Canada; Department of Physiology, Banting and Best Diabetes Centre (D.Z.I.C.) and Heart and Stroke Richard Lewar Centre of Excellence in Cardiovascular Research, Department of Medicine (D.Z.I.C., J.A.U.), University of Toronto, Toronto, ON, Canada; and Women's College Research Institute and Cardiovascular Division, Department of Medicine, Women's College Hospital, Toronto, ON, Canada (J.A.U.).

Published: December 2016

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024764DOI Listing

Publication Analysis

Top Keywords

sodium glucose
4
glucose cotransporter
4
cotransporter inhibitors
4
inhibitors hands
4
hands cardiologists
4
cardiologists great
4
great power
4
power great
4
great responsibility
4
great
2

Similar Publications

The glycocalyx is a layer of villus-like structure covering the luminal surface of vascular endothelial cells. Damage to the glycocalyx has been proven linked to the development of many diseases. However, the factors that promote damage to the glycocalyx are not fully elaborated.

View Article and Find Full Text PDF

Objective: There is limited knowledge about severe urinary tract infections associated with SGLT2i, despite this being the basis for the Food and Drug Administration (FDA) warning. We aim to provide real-world evidence to clarify this relationship further.

Data Source: A literature review was performed in PubMed and Embase for cohort studies published up to August 2024 using PICO-consistent terms.

View Article and Find Full Text PDF

The timely and rational institution of therapy is a key step towards reducing the global burden of chronic kidney disease (CKD). CKD is a heterogeneous entity with varied aetiologies and diverse trajectories, which include risk of kidney failure but also cardiovascular events and death. Developments in the past decade include substantial progress in CKD risk prediction, driven in part by the accumulation of electronic health records data.

View Article and Find Full Text PDF

Chronic kidney disease.

Nat Rev Dis Primers

January 2025

Division of Nephrology, Department of Medicine IV, Hospital of the Ludwig-Maximilians University, Munich, Germany.

Chronic kidney disease (CKD) is defined by persistent abnormalities of kidney function or structure that have consequences for the health. A progressive decline of excretory kidney function has effects on body homeostasis. CKD is tightly associated with accelerated cardiovascular disease and severe infections, and with premature death.

View Article and Find Full Text PDF

The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and updates recommendations on the principles of intensive insulin regimens, including more intensive forms of multiple daily injections with new-generation faster-acting and ultra-long-acting insulins; a summary of adjunctive medications used alongside insulin treatment that includes details on pramlintide, metformin, glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RA) and sodium-glucose cotransporter inhibitors; and key considerations with regard to access to insulin and affordability to ensure that all persons with diabetes who need insulin can obtain it without financial hardship.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!